From chief financial officers to division chiefs, here are 65 cancer center leadership moves Becker’s has covered in 2026:
- City of Hope Cancer Center Chicago appointed David Stewart, MD, chief of surgery.
- Columbus-based Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute appointed Kami Maddocks, MD, chief medical officer.
- Statesville, N.C.-based Iredell Health System named Jeff McDaniels, MSN, RN, director of the 1 North oncology unit at Iredell Memorial Hospital, also in Statesville.
- New York City-based Memorial Sloan Kettering Cancer Center appointed Martin Weiser, MD, chair of the department of surgery.
- Seattle-based Fred Hutch Cancer Center appointed Nida Shekhani executive vice president and chief strategy and clinical growth officer.
- Miami-based Baptist Health Herbert Wertheim Cancer Institute named Alia Abdulla, DO, chief of breast surgical oncology in Plantation, Fla.
- Boston-based Dana-Farber Cancer Institute appointed Andrew Lane, MD, PhD, chief of the division of hematologic neoplasia and named Kathleen Keavany senior vice president of ambulatory care.
- The Medical College of Georgia at Augusta (Ga.) University appointed David Munn, MD, director of the Georgia Cancer Center.
- Nashville, Tenn.-based Vanderbilt-Ingram Cancer Center appointed Fabien Maldonado, MD, and Evan Osmundson, MD, PhD, as co-leaders of its thoracic oncology program.
- City of Hope Cancer Center Chicago appointed Monica Malec, MD, chief of supportive care and integrative oncology.
- Madison, Wis.-based UW Health Carbone Cancer Center appointed Christian Capitini, MD, as director.
- Boston-based Dana-Farber Cancer Institute appointed Ivan Samstein executive vice president and chief finance and business strategy officer.
- Dario Altieri, MD, president and CEO of Philadelphia-based Wistar Institute, a National Cancer Institute-designated basic laboratory cancer center, will join Philadelphia-based Thomas Jefferson University’s Sidney Kimmel Medical College as a special advisor to the director of Jefferson Health’s Sidney Kimmel Comprehensive Cancer Center, also in Philadelphia.
- New York City-based Memorial Sloan Kettering Cancer Center appointed Shakeeb Akhter as chief digital officer.
- Houston-based University of Texas MD Anderson Cancer Center appointed Albert Koong, MD, PhD, chief scientific officer.
- Seattle-based Fred Hutch Cancer Center appointed Chris Li, MD, PhD, senior vice president and director of its public health sciences division.
- Wilmington, Del.-based ChristianaCare appointed Deepak Vadehra, DO, chief of gastrointestinal oncology.
Dr. Vadehra was also appointed director of clinical trials and director of clinical research for solid tumors at ChristianaCare’s Helen F. Graham Cancer Center and Research Institute. - New Orleans-based LCMC Health named Amelia Jernigan, MD, director of the cancer service line.
- David Strickland was named regional CIO of Duarte, Calif.-based City of Hope.
- Houston-based University of Texas MD Anderson Cancer Center appointed Kim Slusser, PhD, RN, inaugural chief nurse executive.
- Tampa, Fla.-based Moffitt Cancer Center named Jon Vineyard vice president of payer strategies.
- Seth Karp, MD, system surgeon-in-chief and chair of the section of surgical sciences for Nashville, Tenn.-based Vanderbilt Health, will step down Oct. 15 to join Boston-based Dana-Farber Cancer Institute as surgeon-in-chief.
Dr. Karp was also appointed chair of the Roberta and Stephen R. Weiner Department of Surgery at Boston-based Beth Israel Deaconess Medical Center. - New Hyde Park, N.Y.-based Northwell Health and the Northwell Cancer Institute tapped Miguel Materin, MD, as system head of ocular oncology.
- New York City-based Montefiore Health System named Ulrich Steidl, MD, PhD, director of the Montefiore Einstein Comprehensive Cancer Center.
- Jacksonville, Fla.-based Nemours Children’s Health appointed David Dickens, MD, as division chief of hematology/oncology for Nemours Children’s Hospital Florida.
- Seattle-based Fred Hutch launched a division of surgical oncology and appointed John Gore, MD, as the inaugural division director.
- Madison, Wis.-based UW Health and the University of Wisconsin School of Medicine and Public Health named Christian Capitini, MD, director of the University of Wisconsin Carbone Cancer Center.
- New York City-based NYU Langone appointed Lisa Roth, MD, as director of the division of pediatric hematology-oncology at Hassenfeld Children’s Hospital, also in New York City.
- Lebanon, N.H.-based Dartmouth Health and Hanover, N.H.-based Dartmouth Geisel School of Medicine named Roy Herbst, MD, PhD, director of the Dartmouth Cancer Center.
- New York City-based Memorial Sloan Kettering Cancer Center appointed Steve Glass as executive vice president and chief financial officer.
- Omaha-based Fred & Pamela Buffett Cancer Center, part of the University of Nebraska Medical Center, tapped Kathleen Moore, MD, as deputy director.
- Philadelphia-based Temple University Health System appointed Robert Winn, MD, as director of the Fox Chase Cancer Center.
- Richmond, Va.-based VCU Health Massey Comprehensive Cancer Center named Monica Baskin, PhD, as interim director.
- Seattle-based Fred Hutch Cancer Center appointed Mazyar Shadman, MD, and Vyshak Alva Venur, MD, as deputy chief medical officers.
- Coral Gables, Fla.-based Baptist Health South Florida appointed Robert Press, MD, as clinical director of proton therapy at the Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton (Fla.) Regional Hospital.
- Mobile, Ala.-based USA Health tapped Brian Persing, MD, as director of the USA Health Mitchell Cancer Institute.
- Irving, Texas-based Christus Health tapped Steven DiBiase, MD, as medical director of the Christus Cancer Center in Longview, Texas.
- Duarte, Calif.-based City of Hope named Alexey Danilov, MD, PhD, as associate director for clinical sciences.
- Valdosta, Ga.-based SGMC Health tapped Nicole Centers to serve as director of the Pearlman Cancer Center. Ms. Centers was also appointed administrative director of oncology for the health system.
- Stanford (Calif.) Cancer Institute tapped Vivek Subbiah, MD, as inaugural associate director for drug development and precision oncology. Dr. Subbiah was also appointed as executive medical director for cancer novel therapies and clinical trial network development at Stanford (Calif.) Health Care.
- Houston Methodist has tapped Daniela Matei, MD, as director of the Dr. Mary and Ron Neal Cancer Center.
- Seattle-based Fred Hutch Cancer Center named Holly Harris, PhD, the inaugural Bus Family Endowed Chair and Jonathan Bricker, PhD, as the Endowed Chair in Cancer Prevention.
- Philadelphia-based Fox Chase Cancer Center appointed David Weinberg, MD, as vice president and physician lead of the cancer screening and prevention service line. Dr. Weinberg will also serve as the associate director of cancer screening and prevention at the Institute for Cancer Research.
- Charlotte, N.C.-based Advocate Health tapped Stephanie Nasello as division vice president of cancer at Milwaukee-based Aurora Health Care.
- Peoria, Ill.-based OSF HealthCare tapped Robert McWilliams, MD, as deputy director of the OSF Cancer Institute.
- Philadelphia-based Fox Chase Cancer Center and Temple University Health tapped James Ferriss, MD, as system chief of gynecologic oncology.
- Weston-based Cleveland Clinic Florida tapped Manpreet Bedi, MD, as division chair of radiation oncology.
- The University of Cincinnati Cancer Center tapped David Gius, MD, PhD, as director.
- Duarte, Calif.-based City of Hope appointed Marwan Fakih, MD, as deputy director.
- Philadelphia-based Fox Chase Cancer Center appointed Alex Khariton as COO.
- Jacksonville, Fla.-based Baptist Health tapped Robert Press, MD, as clinical director of proton therapy at the Eugene M. and Christine E. Lynn Cancer Institute in Boca Raton, Fla.
- Duarte, Calif.-based City of Hope named Gordon Groschl vice president and chief information security officer.
- New York City-based NYU Langone Health appointed Anirban Maitra, MD, as director of the Laura and Isaac Perlmutter Cancer Center.
- The Knight Cancer Institute at Portland-based Oregon Health & Science University appointed Joel Helmke as CEO of the Knight Cancer Group.
- Tampa (Fla.) General Hospital appointed Gustavo Rivero, MD, as director of translational research for hematologic malignancies.
- Duarte, Calif.-based City of Hope named Vanessa Almendro Navarro, PhD, as chief commercialization officer.
- New Brunswick, N.J.-based RWJBarnabas Health and the Rutgers Cancer Institute appointed Kathie-Ann Joseph, MD, as chief of breast surgery. Dr. Joseph will also serve as co-director of the multidisciplinary breast program at the Rutgers Cancer Institute and the Jack & Sheryl Morris Cancer Center.
- Houston-based Baylor College of Medicine appointed Will Parsons, MD, PhD, as chief of the division of hematology-oncology in the department of pediatrics. Dr. Parsons will also serve as director of Texas Children’s Cancer and Hematology Center.
- Duarte, Calif.-based City of Hope named Marcee Chmait as head of emerging opportunities and ventures.
- Baptist Health Miami Cancer Institute tapped Justin Dubin, MD, as director of men’s sexual health.
- Duarte, Calif.-based City of Hope appointed Leo Wang, MD, PhD, as division chief of cell, gene and transplantation therapy in the department of pediatrics.
- Richmond, Va.-based VCU Massey Comprehensive Cancer Center appointed Dimple Patel, PhD, as associate director of innovation, leadership and professional development. Dr. Patel will also lead operations and strategy of the Executive Leadership Academy for Cancer Centers.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.